A Breakthrough in Biotech May Put Investors at an Advantage
Think about what would happen if a company were to find a cure for diabetes? Investors are flocking to start-ups with promising treatments & 1 small company may hold the key.
Tiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-tolerated and Produced Positive Trend in Biomarkers of Immunomodulation and Anti-inflammation in Healthy Volunteers
NEW YORK–(BUSINESS WIRE)– THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY…
